Accelerate Clinical Successwith Single-Cell GenAI at Scale
Turning single-cell clarity into cancer therapeutic opportunity
Make Every CellCount
We illuminate cancer's cellular secrets, driving therapeutic breakthroughs from targets to biomarkers that conventional methods miss.
The Stratification Dilemma
Too expensive, Too long & Too hard
What if we could get you single-cell clarity from your bulk or image samples?
Turn Uncertainty Into Confidence
Regulator-ready patient stratification
without the single-cell burden
How We De-Risk Your Journey
Virtual Cell technology transforms your archived bulk RNA samples or
pathological image data including H&E, IHC into
regulator-ready stratification insights
Accelerate Enrollment
Identify true responder populations with 7x higher precision, reducing screen failures and meeting recruitment timelines.
Predict Responders Earlier
Model patient responses before dosing, enabling earlier go/no-go decisions and reducing late-stage failures.
Unlock Hidden Value
Extract cellular-level biomarkers from archived bulk RNA samples, revealing stratification opportunities you already paid for.
Stratify At Trial Scale
Profile 1,000 patients for the cost of 150 single-cell samples, making comprehensive stratification economically feasible.
Trusted By
Leading
Programs
Validated across 5+ cancer types with pharma and academic partners